Marshall Wace’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$2.53M Buy
2024
Q2
$1.02M Sell
2024
Q1
$18.1M Buy
2023
Q4
$1.97M Buy
2023
Q3
Sell
2023
Q2
$2.52M Sell
2023
Q1
$4.98M Buy
2022
Q4
$307K Buy
2022
Q3
Sell
2022
Q2
$1.46M Buy
2022
Q1
$406K Buy
2021
Q4
$335K Sell
2021
Q3
$1.96M Buy
2021
Q2
$512K Buy
2021
Q1
$362K Sell
2020
Q4
$1.23M Buy